France Launches Pilot Program to Boost Senior Vaccination Rates in Loire Region
Public health officials in France have unveiled a four-year initiative aimed at significantly increasing vaccination rates among seniors in the Loire department, part of a broader effort to protect older adults from preventable diseases.
The program, known as Prevax 42, was officially launched on April 27, 2026, with the goal of raising vaccination coverage among residents aged 65 and older by 20% by 2028. The Loire department, along with three others—Isère, Rhône and Haute-Savoie—has been selected as a pilot site for the campaign, which focuses on vaccines for influenza, COVID-19, pneumococcal disease, shingles, and respiratory syncytial virus (RSV).
Current vaccination rates in the Loire region fall below national averages, according to health authorities. Only 53.4% of seniors in the department have received the flu vaccine, while COVID-19 vaccination stands at 30%. Even lower are the rates for pneumococcal (9.9%), shingles (under 5%), and RSV vaccines. The initiative aims to push flu vaccination rates to 75% among seniors by 2028, a target that health experts say could reduce hospitalizations and complications from preventable illnesses.
“Vaccination is one of the best ways to age in good health,” said Professor Elisabeth Botelho-Nevers, head of infectious diseases at Saint-Étienne University Hospital. “It protects older adults not just from the disease itself, but from the burden of complications that can lead to hospitalization and loss of independence.”
The Prevax 42 program is a collaboration between the Auvergne-Rhône-Alpes Gerontopole and Saint-Étienne University Hospital. Officials say the multi-year effort will involve community outreach, education campaigns, and partnerships with local healthcare providers to address barriers to vaccination. While specific strategies have not been detailed, the program reflects growing concern over declining immunization rates among older populations, a trend observed in many high-income countries.
Health experts emphasize that vaccines play a critical role in preventing severe outcomes from infectious diseases, particularly for seniors with underlying health conditions. The pilot program in the Loire region could serve as a model for other areas if successful, offering insights into effective strategies for improving vaccine uptake in aging populations.
Public health campaigns like Prevax 42 highlight the ongoing challenge of maintaining high vaccination rates as misinformation and vaccine fatigue persist. For older adults, staying up to date on recommended vaccines is a key component of preventive care, helping to reduce the risk of serious illness and preserve quality of life.
